Mounjaro and PayPal Pay in 3: Splitting the Cost of a Prescription Medicine

What official UK pricing guidance tells us about Mounjaro's cost trajectory

Mounjaro's price position in the UK shifted materially in late 2025. Eli Lilly raised the list price of its tirzepatide pens from 1 September 2025, the highest-dose pen moved from around £122 to around £330 at list price, and private providers followed. If you want to understand exactly what drove those increases, the reasons behind Mounjaro prices rising are worth reading before you plan your budget. That's a meaningful range, and it means the figure you're splitting across three PayPal instalments could be quite different depending on where you are in the treatment schedule.

Understanding that range matters because of how tirzepatide is titrated. Treatment starts at 2.5mg (a dose designed to help your body adjust, not the therapeutic target) and is stepped up by the prescriber over time, typically in four-week intervals. So the monthly cost at the start of treatment is often different from what it will be later. Any payment plan based purely on the starter price is worth revisiting with your prescriber or pharmacy as your dose changes. The full Mounjaro price picture in the UK is worth reading before you commit to a split-payment arrangement, so nothing catches you off guard.

NICE recommended tirzepatide for weight management in December 2024 (TA1026), confirming the clinical evidence base. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at 15mg over 72 weeks among adults with obesity. That evidence is what underpins the medicine's UK licence, and it's also why clinically supervised treatment, regardless of how it's paid for, is the standard that matters.

PayPal Pay in 3 and prescription medicines: what actually happens at checkout

PayPal Pay in 3 works by splitting the checkout total into three equal interest-free payments, taken roughly a month apart. Some regulated online pharmacies do offer it. Others use Mounjaro Clearpay as a way to spread the cost, or a monthly payment arrangement structured differently. A handful offer their own staged billing. The presence or absence of any particular payment option tells you very little about the quality of the clinical service behind it.

What the payment method cannot do is replace the clinical assessment. Every dispensing of a prescription-only medicine requires a prescriber to review the patient's information and judge suitability. A pharmacy that allows checkout to proceed before that review is complete is not operating within the expected regulatory framework. So when you're evaluating whether a provider's PayPal Pay in 3 option is worth using, the first check isn't the payment terms, it's whether you can verify them on the GPhC register at pharmacyregulation.org/registers. That takes under a minute and tells you immediately whether the pharmacy is registered to dispense in the UK.

If you want to compare the instalments-based options available, how Pay in 3 for Mounjaro works covers the mechanics in more detail, including what to check across different providers.

The right question to ask when comparing payment plans for Mounjaro

It's tempting to approach this by asking which provider offers the lowest instalment. That's understandable, Mounjaro is not cheap, and spreading the cost feels sensible. But the instalment amount is a function of the total price, and the total price only makes sense once you know what it actually includes.

Some providers list the medicine price alone. Others bundle in the consultation, prescription and delivery. At nume, there is one price that covers everything: the consultation, the prescriber's review, the prescription, the medicine and free next-working-day delivery tracked by DPD, with aftercare available seven days a week. No subscription. Every repeat order is reviewed again by a clinician before it goes out. Whether or not a particular payment method is available at checkout, the thing that doesn't vary is that a real prescriber, not an algorithm, looks at your case the same day.

For a broader view of the treatment itself (how it works, who it's licensed for, and what a private clinical assessment involves) the Mounjaro treatment overview covers all of that. And if you're still weighing up whether a GLP-1 medicine is the right direction, the weight-loss treatments page sets out the options side by side.

The MHRA has been clear that these medicines should not be obtained without a prescription or from sources that cannot be verified as licensed, fake pens have been seized in significant quantities across the UK, and some have contained entirely different substances. Any seller offering Mounjaro without requiring a prescription, or advertising prices far below the market range, is a red flag worth taking seriously. You can report suspected sellers at the MHRA's Yellow Card site.